Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway.

导出 LinkOut

翻译打印收藏纠错

第一作者： Rui,Zhou

第一单位： Department of Nutrition, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

作者： Rui,Zhou ^[1] ; Chuman,Lin ^[2] ; Yanzhen,Cheng ^[3] ; Xiaoyun,Zhuo ^[1] ; Qinghua,Li ^[4] ; Wen,Xu ^[4] ; Liang,Zhao ^[1] ; Li,Yang ^[4]

作者单位： Department of Nutrition, Zhujiang Hospital, Southern Medical University, Guangzhou, China. ^[1] Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China. ^[2] Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. ^[3] Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. ^[4] Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. ^[5]

关键词 PPARα T2DM hepatic steatosis liraglutide liver injury

DOI 10.3389/fphar.2020.600175

PMID 33746742

发布时间 2021-03-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2020年11卷

600175页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除